Education
About Us
Working with TipRanks
Follow Us
Daniel Rollings Karlin Insider Profile
4 Followers
Daniel Rollings Karlin, Chief Medical Officer at Definium Therapeutics, holds 70.41K shares in Definium Therapeutics (Ticker: DFTX). Most recently, Daniel Rollings Karlin ― shares of Definium Therapeutics on ― for an estimated value of ―.
Daniel Rollings Karlin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Daniel Rollings Karlin's holdings
Insider Roles
Chief Medical Officer
Roles that Daniel Rollings Karlin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Rollings Karlin
Daniel Rollings Karlin's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Rollings Karlin's performance on stock
You May Also Like
Daniel Rollings Karlin insider profile FAQ
What is the percentage of profitable transactions made by Daniel Rollings Karlin?
The percentage of profitable transactions made by Daniel Rollings Karlin is ―.
What is the average return per transaction made by Daniel Rollings Karlin?
The average return per transaction made by Daniel Rollings Karlin is ―.
What stocks does Daniel Rollings Karlin hold?
Daniel Rollings Karlin holds: DFTX stocks.
What was Daniel Rollings Karlin’s latest transaction?
Daniel Rollings Karlin latest transaction was an Uninformative Buy of ―.
What was Daniel Rollings Karlin's most profitable transaction?
Daniel Rollings Karlin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Rollings Karlin's role in Definium Therapeutics?
Daniel Rollings Karlin's role in Definium Therapeutics is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.